表紙
市場調査レポート

癌のメディカルアフェアーズの評判(米国):癌専門医による主要製品・企業の格付け

Medical Affairs Reputations in Oncology (US): Oncologists Rate Key Products and Companies

発行 FirstWord 商品コード 310626
出版日 ページ情報 英文 54 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
癌のメディカルアフェアーズの評判(米国):癌専門医による主要製品・企業の格付け Medical Affairs Reputations in Oncology (US): Oncologists Rate Key Products and Companies
出版日: 2014年08月14日 ページ情報: 英文 54 Pages
概要

当レポートでは、4つの主要適応症(乳癌、メラノーマ、非小細胞肺癌(NSCLC)および腎細胞癌)にわたる12のメディカルアフェアーズチームの実績および医師の満足度について分析しており、評価対象となっている製品の比較分析、市場概要、および競合環境における各製品のポジションの調査をまとめ、お届けいたします。

本レポートが取り扱う主な疑問

  • 癌専門家は癌、メラノーマ、非小細胞肺癌(NSCLC)および腎細胞癌分野におけるメディカルアフェアーズチームの役割をどのように理解しているか?
  • 医師はどのようにメディカルアフェアーズチームのサービスを利用するか?
  • メディカルアフェアーズチームと医師の間の最適な意思疎通の頻度は?
  • 競合環境における各製品のポジションは?
  • メディカルアフェアーズチームのどの性質が競合上の優位性を最も促進する可能性があるか?
  • メディカルアフェアーズサポートにとって、最善のサービスを提供し最高の格付けを獲得するのはどの医薬品か?
  • 企業・ブランドのポジショニングおよびコミュニケーションにとっての機会は?
目次
Product Code: 596200283

As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more critical.

Fine tuning their performance through smarter delivery and high quality interaction is an increasingly important aspect of establishing and maintaining front line, product level access and education.

In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord provides robust insight on the performance and physician satisfaction across 12 Medical Affairs teams across 4 key indications; Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma .

Using its proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers an important new advanced analysis of survey results that is both timely and critical to the current oncology drugs market.

What is EdgeMap Analysis?

This report includes slides that provide advance analysis of the survey results using EdgeMap analysis, a proprietary analytics tool. EdgeMap provides an integrated, comparative analysis of the competitive set of products being evaluated in the study. It offers an overview of the market and provides a clear portrait of each product's position within its competitive environment.

Key Benefits

In this report, gain insight from key pharma stakeholders with a vested interest in physician perspectives on oncology brand performance.

  • Gain insight into how oncologists and haematologist-oncologists rate Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell Carcinoma
  • Understand the key issues for which physicians require Medical Affairs team support
  • Learn which attributes physicians most value in relation to Medical Affairs team services
  • Identify which marketed and pipeline products were rated most highly across numerous measures
  • Determine which media and frequency of interaction is perceived the most positively
  • Benefit from FirstWord's proprietary analytics tool, EdgeMap and Need-Gap. EdgeMap offers an integrated, comparative analysis of the evaluated products. Need-Gap provides guidance on opportunities for brand positioning and communication.

Top Report Features

Filled with charts and up-to-the-minute survey analysis, this report offers:

  • Precise and timely EdgeMap and Need-Gap analytics into the perceptions around Medical Affairs team performances and areas of improvement
  • Overview of key rankings for eight marketed and four pipeline products
  • Examination of physicians' current usage of Medical Affairs teams services
  • Key findings regarding the most and least important attributes of Medical Affairs teams to physicians

Get Answers to these Questions

  • How do oncologists perceive the role of Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell Carcinoma?
  • How do physicians use Medical Affairs teams' services?
  • What is the optimal frequency of interactions between Medical Affairs teams and physicians?
  • What is each product's position within its competitive environment?
  • Which attributes of Medical Affairs teams are most likely to drive competitive advantage?
  • Which drugs offered the best service and claimed the highest ratings for Medical Affairs support?
  • What are the opportunities for corporate and brand positioning and communication?

What is Need-Gap Analysis?

This report includes slides that provide advance analysis of the survey results using Need-Gap analysis, a proprietary analytics tool. Need-Gap Analysis is useful for establishing areas of unmet need and hence provides valuable guidance on opportunities for corporate and brand positioning and communication.

Key Takeaways

Medical Affairs teams, Marketing Directors and Competitive Intelligence units can use this report to:

  • More precisely analyse physicians' needs and areas of concern
  • Improve team responsiveness and traction with oncologists
  • Better deliver key messaging and identify areas of weakness
  • Provide accurate, scientifically up-to-date product information in the areas of the most need
  • Understand how competitors are performing and what improvements need to be made
  • Tailor interaction frequency, media and approach

Key Fact: Screening Criteria

Respondents were screened to ensure these requirements were met:

  • See at least 5 patients for NSCLC, Melanoma, RCC and breast cancer (for each condition), and they see at least 100 patients in a typical month
  • Have been in active practice between 5-35 years
  • Devote at least 50% of time to direct patient care
  • Interaction with the medical affairs professional in the past 6 months for at least one of the listed products

Table of Contents

Current Status of Interactions with Different Medical Affairs Teams

  • Interactions in the past 6 months with medical affairs teams for each product
  • Details of interactions on different aspects
  • Current frequency of interactions with medical affair teams for each product

Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes

  • Evaluation of overall quality of interactions with medical affairs teams for each product
  • Attribute importance of medical affairs teams roles to physicians' practice
  • EdgeMap analysis by therapy area - competitive evaluation on medical affairs teams performance on attributes
  • Competitive Evaluation of physicians satisfaction of interaction with medical affairs
  • Need-Gap analysis by product

Preferred Interaction Media, Frequency, and Suggestions for Improvement

  • Preferred interaction media and frequency
  • Suggestions for improvement

Appendix

  • Physician profile
  • Detailed satisfaction scores
Back to Top